Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
133
Views
79
CrossRef citations to date
0
Altmetric
Original Research

M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer

Lili Cao1 Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China;2 Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China
,
Xiaofang Che1 Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China;2 Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China
,
Xueshan Qiu3 Department of Pathology, College of Basic Medical Sciences of China Medical University, Shenyang 110001, People’s Republic of China
,
Zhi Li1 Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China;2 Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China
,
Bowen Yang1 Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China;2 Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China
,
Shuo Wang1 Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China;2 Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China
,
Kezuo Hou1 Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China;2 Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China
,
Yibo Fan1 Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China;2 Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China
,
Xiujuan Qu1 Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China;2 Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China
&
Yunpeng Liu1 Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of China;2 Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang 110001, People’s Republic of ChinaCorrespondence[email protected] [email protected]
 show all
Pages 6125-6138 | Published online: 04 Jul 2019

Citations (79)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (79)

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.